These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 15699173)

  • 21. Effect of tetravalent bispecific CD19xCD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells.
    Reusch U; Le Gall F; Hensel M; Moldenhauer G; Ho AD; Little M; Kipriyanov SM
    Int J Cancer; 2004 Nov; 112(3):509-18. PubMed ID: 15382079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ZAP-70 and SLP-76 regulate protein kinase C-theta and NF-kappa B activation in response to engagement of CD3 and CD28.
    Herndon TM; Shan XC; Tsokos GC; Wange RL
    J Immunol; 2001 May; 166(9):5654-64. PubMed ID: 11313406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential activation through the TCR-CD3 complex affects the requirement for costimulation of human T cells.
    Kawaguchi M; Eckels DD
    Hum Immunol; 1995 Jun; 43(2):136-48. PubMed ID: 7591873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simplified process for the production of anti-CD19-CAR-engineered T cells.
    Tumaini B; Lee DW; Lin T; Castiello L; Stroncek DF; Mackall C; Wayne A; Sabatino M
    Cytotherapy; 2013 Nov; 15(11):1406-15. PubMed ID: 23992830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS; Yamada K; Womer KL; Pillsbury EP; Allison KS; Marolewski AE; Geng D; Thall AD; Arn JS; Sachs DH; Sayegh MH; Madsen JC
    J Immunol; 2000 Mar; 164(6):3434-44. PubMed ID: 10706740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between the expression of CD25 and CD69 on the surface of lymphocytes T and B from peripheral blood and bone marrow of patients with chronic lymphocytic leukemia and established prognostic factors of this disease.
    Grywalska E; Bartkowiak-Emeryk M; Pasiarski M; Olszewska-Bożek K; Mielnik M; Podgajna M; Pieczykolan M; Hymos A; Fitas E; Surdacka A; Góźdź S; Roliński J
    Adv Clin Exp Med; 2018 Jul; 27(7):987-999. PubMed ID: 29893517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.
    Klaus GG; Holman M; Johnson-Léger C; Christenson JR; Kehry MR
    Int Immunol; 1999 Jan; 11(1):71-9. PubMed ID: 10050675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T cell stimulation and expansion by SunTag-based clustering of anti-CD3/CD28 scFv.
    Zhong K; Liu Z; Li H; Zhao S; Wang Y; Guo W; Zheng X; Yang H; Guo G; Zhou L; Xu J; Tong A
    Aging (Albany NY); 2020 Jun; 12(11):11061-11070. PubMed ID: 32526703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of B-CLL by autologous and allogeneic host nonreactive anti-third-party CTLs.
    Arditti FD; Aviner S; Dekel B; Krauthgamer R; Gan J; Nagler A; Tabilio A; Martelli M; Berrebi A; Reisner Y
    Blood; 2005 Apr; 105(8):3365-71. PubMed ID: 15238417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T-CLL).
    Zocchi MR; Poggi A; Heltai S; Villa A; Inverardi L; Vicari A; Sabbadini MG; Ferrarini M
    Clin Exp Immunol; 1990 Oct; 82(1):108-13. PubMed ID: 1976463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new recombinant single chain trispecific antibody recruits T lymphocytes to kill CEA (carcinoma embryonic antigen) positive tumor cells in vitro efficiently.
    Wang XB; Zhao BF; Zhao Q; Piao JH; Liu J; Lin Q; Huang HL
    J Biochem; 2004 Apr; 135(4):555-65. PubMed ID: 15115782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro analysis of CD40-CD154 and CD28-CD80/86 interactions in the primary T-cell response to allogeneic "nonprofessional" antigen presenting cells.
    Laning JC; Deluca JE; Isaacs And CM; Hardin-Young J
    Transplantation; 2001 May; 71(10):1467-74. PubMed ID: 11391237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GMP production and testing of Xcellerated T Cells for the treatment of patients with CLL.
    Hami LS; Green C; Leshinsky N; Markham E; Miller K; Craig S
    Cytotherapy; 2004; 6(6):554-62. PubMed ID: 15764021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
    Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
    Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL
    Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cell receptor-triggered activation of intraepithelial lymphocytes in vitro.
    Gramzinski RA; Adams E; Gross JA; Goodman TG; Allison JP; Lefrançois L
    Int Immunol; 1993 Feb; 5(2):145-53. PubMed ID: 8383994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engagement of CD153 (CD30 ligand) by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+ IgM+ B cells.
    Cerutti A; Schaffer A; Goodwin RG; Shah S; Zan H; Ely S; Casali P
    J Immunol; 2000 Jul; 165(2):786-94. PubMed ID: 10878352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.